NIH Director's Blog: Drug Development

OCTOBER 11, 2022

Barry Sharpless, Scripps Research, La Jolla, CA, October 5, 2022 marked the second time that he’s received an early-morning congratulatory call from The Royal Swedish Academy of Sciences. 2001, 40 (11), 2004–2021 [2] A stepwise huisgen cycloaddition process: Copper(I)-catalyzed regioselective “Llgation” of azides and terminal alkynes.

Research 52

Research Small Molecule Science Clinical Research 52

Drug Discovery World

OCTOBER 16, 2023

This environment of research excellence, in turn, fosters R&D, innovation, spin-offs, start-ups, networking, collaboration and entrepreneurship, which sets a sturdy foundation that attracts funding, and creates an appealing work culture. It has a vibrant community of life-science companies, from global pharma to smaller start-ups.

Drugs 189

Drugs Science Therapies Targeted Protein Degradation 189

The Pharma Data

DECEMBER 15, 2020

SH) was founded in Shenzhen on 2001, specializing in the research and development of novel small molecule drugs. At present, the company has developed a number of original new drug product lines for oncology, metabolic diseases, autoimmune diseases, central nervous diseases, and antiviral diseases.

Pharmaceuticals 40

Pharmaceuticals Small Molecule Clinical Trials Production 40

Drug Discovery World

OCTOBER 7, 2022

Response-mode funding for drug discovery is being administered from the therapeutic division of the organisation for the first time, allowing for strategic build of a fully aligned portfolio stemming from the earliest stages of translational activity. . RA: How can the integration of industry and academia help streamline drug development?

Pharma Companies 130

Pharma Companies Science Research Drug Development 130